/Investor DB

Neva Sgr. — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Nuclidiumnuclidium.cominSeries B · May 2026 · $34M

Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.

BiotechDeep TechHealthtechMedical DevicesBasel, CH

Leila Jaafar(CEO)Gustav(Medical Advisor)

Co-investorsAngelini VenturesDeepTech & Climate FondsKurma PartnersVIVES Partners

Straikerstraiker.aiin𝕏Jul 2026 · $64M

Straiker builds security software for enterprise AI agents, offering agent discovery, autonomous red teaming for attack paths, and runtime protection across tools, data, MCP servers, and workflows.

AI & Machine LearningCybersecurityEnterprise SoftwareMountain View, US

Ankur Shah(Founder)inSreenath Kurupati(Founder)in

Co-investorsBain Capital VenturesGTM CapitalLightspeed Venture PartnersRain CapitalCiti VenturesIlluminate Financial+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.